Skip to content

Abstract 9996: Differential Effects of Ovarian Hormone Deprivation and Empagliflozin on Cardiac Remodeling in Type 2 Diabetic Mice

Nov 2026 · Circulation · 0 citations

Abstract

Background: Type 2 diabetes (T2D) contributes to adverse cardiac remodeling, while female sex hormone deprivation further increases susceptibility to metabolic disorders. Although randomized controlled trials have demonstrated that sodium-glucose cotransporter-2 inhibitors (SGLT2i) can reduce left ventricular mass in patients with T2D, data regarding these effects in a sex hormone-deprivation state remain limited. Purpose: To investigate the effects of ovarian hormone deprivation and empagliflozin treatment on cardiac remodeling in T2D mice. Methods: Thirty-five female C57BL/6 mice were sham-operated (S) or ovariectomized (OVX) at 8 weeks of age. T2D was induced using a high-fat high-sucrose diet for 8 weeks with three low-dose (40 mg/kg) streptozotocin injections (HZ) at week 17. T2D was confirmed at week 25. From weeks 25 to 34, mice in the treatment groups received empagliflozin (E) (10 mg/kg/day) mixed into the diet, resulting in 5 groups: control, S+HZ, S+HZ+E, OVX+HZ, and OVX+HZ+E (7 mice per group). Fibrosis and hypertrophy were quantified on Sirius Red- and H&E-stained sections using ImageJ. mRNA expression was assessed by RT-qPCR. Serum galectin-3 was evaluated by ELISA. Data was analyzed using ANOVA with appropriate pairwise comparisons. Results: At 25 weeks old, OVX mice had a higher fasting glucose level than sham-operated mice (375±67 vs 219±84 mg/dL, P <0.001), without a difference in fasting insulin levels. Regarding hypertrophy, cardiomyocyte cross-sectional area was significantly increased in the S+HZ and OVX+HZ groups compared with the control. Empagliflozin treatment and ovariectomy were associated with lower cross-sectional area ( P Empa =0.02, P OVX =0.04). In terms of gene expression, myosin heavy chain 7 ( Myh7 ) was upregulated only in the S+HZ group ( P <0.001) and was attenuated by empagliflozin treatment ( P <0.001). The OVX+HZ group had lower Myh7 expression than the S+HZ group ( P =0.01). Bax , a pro-apoptotic gene, was upregulated in both S+HZ ( P <0.001) and, with a lesser degree, in OVX+HZ groups ( P =0.04), compared with the control. Empagliflozin treatment reduced Bax expression, with a greater extent in sham-operated mice ( P <0.001). Regarding fibrosis, fibrotic area was increased in OVX mice ( P =0.008), but not in sham-operated mice. Compared to control, collagen, type I, alpha 1 ( Col1a1 ) mRNA expression was increased in most groups. Empagliflozin treatment did not significantly affect either Col1a1 expression or fibrotic area. Serum galectin-3, a fibrotic marker, was significantly increased in OVX mice ( P <0.001), but not in sham-operated mice. Conclusions: In this model, ovarian hormone deprivation is associated mainly with cardiac fibrosis. Empagliflozin reduced markers of hypertrophic remodeling, with differential molecular effects according to ovarian hormone status, whereas fibrotic changes were largely unaffected.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.